These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 37746997)
1. Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma. Ying J; Hong H; Yu C; Jiang M; Ding D Medicine (Baltimore); 2023 Sep; 102(38):e34954. PubMed ID: 37746997 [TBL] [Abstract][Full Text] [Related]
2. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. Zhang X; Wu Z; Ma K BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944 [TBL] [Abstract][Full Text] [Related]
3. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets. Liu F; Wu H J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689 [TBL] [Abstract][Full Text] [Related]
4. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates. Fan K; Zhang BH; Han D; Sun YC BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494 [TBL] [Abstract][Full Text] [Related]
5. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma. Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904 [TBL] [Abstract][Full Text] [Related]
6. PHD3 as a Prognosis Marker and its Relationship with Immune Infiltration in Lung Adenocarcinoma. Wang L; Zhong Y; Wang G; An H; Gao Q; Ye Y Comb Chem High Throughput Screen; 2022; 25(13):2255-2263. PubMed ID: 35088661 [TBL] [Abstract][Full Text] [Related]
7. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
8. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma. Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453 [TBL] [Abstract][Full Text] [Related]
9. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma. Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392 [TBL] [Abstract][Full Text] [Related]
10. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma. Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488 [TBL] [Abstract][Full Text] [Related]
11. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma. Jiang W; Wei Q; Xie H; Wu D; He H; Lv X Anal Cell Pathol (Amst); 2023; 2023():4522045. PubMed ID: 37416927 [TBL] [Abstract][Full Text] [Related]
12. Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128 [TBL] [Abstract][Full Text] [Related]
13. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650 [No Abstract] [Full Text] [Related]
14. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642 [TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation. Zou X; Guo B; Ling Q; Mo Z Front Mol Biosci; 2022; 9():832238. PubMed ID: 35127830 [No Abstract] [Full Text] [Related]
16. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma. Hu Y; Liu Y; Ma C; Ai K Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082 [TBL] [Abstract][Full Text] [Related]
17. Expression profile of Toll‑like receptors in human breast cancer. Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409 [TBL] [Abstract][Full Text] [Related]
18. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310 [TBL] [Abstract][Full Text] [Related]
19. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma. Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786 [TBL] [Abstract][Full Text] [Related]
20. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. Nishiya T; DeFranco AL J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]